{"d":{"__metadata":{"id":"https://ws.parlament.ch/OData.svc/Business(ID=20267005,Language='FR')","uri":"https://ws.parlament.ch/OData.svc/Business(ID=20267005,Language='FR')","type":"itsystems.Pd.DataServices.DataModel.Business"},"BusinessResponsibilities":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20267005,Language='FR')/BusinessResponsibilities"}},"RelatedBusinesses":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20267005,Language='FR')/RelatedBusinesses"}},"BusinessRoles":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20267005,Language='FR')/BusinessRoles"}},"Publications":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20267005,Language='FR')/Publications"}},"LegislativePeriods":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20267005,Language='FR')/LegislativePeriods"}},"Sessions":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20267005,Language='FR')/Sessions"}},"Preconsultations":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20267005,Language='FR')/Preconsultations"}},"Bills":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20267005,Language='FR')/Bills"}},"Councils":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20267005,Language='FR')/Councils"}},"BusinessTypes":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20267005,Language='FR')/BusinessTypes"}},"Votes":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20267005,Language='FR')/Votes"}},"SubjectsBusiness":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20267005,Language='FR')/SubjectsBusiness"}},"BusinessStates":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20267005,Language='FR')/BusinessStates"}},"Council":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20267005,Language='FR')/Council"}},"Transcripts":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20267005,Language='FR')/Transcripts"}},"ID":20267005,"Language":"FR","BusinessShortNumber":"26.7005","BusinessType":14,"BusinessTypeName":"Heure des questions. Question","BusinessTypeAbbreviation":"Qst.","Title":"Enfin la lumi\u00e8re sur les contrats des \"vaccins\" Covid ?","Description":null,"InitialSituation":null,"Proceedings":null,"DraftText":null,"SubmittedText":"<p>A la suite des arr\u00eats A-448/2024, A-514/2024 et A-619/2024 du Tribunal administratif f\u00e9d\u00e9ral du 10 f\u00e9vrier 2026, le Conseil f\u00e9d\u00e9ral va-t-il imposer \u00e0 l'OFSP le respect du principe l\u00e9gal de transparence et lui ordonner de renoncer \u00e0 saisir le Tribunal f\u00e9d\u00e9ral et de publier enfin, sans caviardage, les contrats que la Conf\u00e9d\u00e9ration a conclus avec des fabricants de \"vaccins\" contre le Covid-19 ?</p>","ReasonText":null,"DocumentationText":null,"MotionText":null,"FederalCouncilResponseText":"<span><p>Le DFI et l\u2019OFSP ont pris connaissance des arr\u00eats mentionn\u00e9s et les ont examin\u00e9s attentivement. L\u2019OFSP renonce \u00e0 porter l\u2019affaire devant le Tribunal f\u00e9d\u00e9ral (TF).</p><p>&nbsp;</p><p>Alors que les n\u00e9gociations relatives aux contrats d\u2019acquisition des vaccins contre le COVID-19 restent largement confidentielles \u00e0 l\u2019\u00e9chelle internationale, les arr\u00eats du TAF, s\u2019ils devenaient ex\u00e9cutoires, feraient apparemment de la Suisse le seul pays europ\u00e9en \u00e0 publier ces contrats. Cette situation risque d\u2019affaiblir la position de notre pays lors de n\u00e9gociations visant \u00e0 acqu\u00e9rir des vaccins lors d\u2019une future pand\u00e9mie. Aujourd\u2019hui toutefois, quelques ann\u00e9es apr\u00e8s la pand\u00e9mie, les contrats d\u2019acquisition de vaccins ne r\u00e9sonnent plus autant avec l\u2019actualit\u00e9 que pendant la crise. De plus, afin de r\u00e9pondre au besoin d\u2019information de la population, l\u2019OFSP applique ordinairement une pratique aussi transparente que possible en mati\u00e8re de publication.</p><p>&nbsp;</p><p>Pour l\u2019heure, il faut attendre de voir si les arr\u00eats deviendront ex\u00e9cutoires. En effet, les fabricants de vaccins concern\u00e9s ont aussi le droit de d\u00e9poser un recours aupr\u00e8s du TF pour d\u00e9fendre leurs int\u00e9r\u00eats, en particulier en mati\u00e8re de secret professionnel, d\u2019affaires ou de fabrication.</p></span>","FederalCouncilProposal":null,"FederalCouncilProposalText":null,"FederalCouncilProposalDate":"\/Date(1773014400000)\/","SubmittedBy":"Addor Jean-Luc","BusinessStatus":229,"BusinessStatusText":"Liquid\u00e9","BusinessStatusDate":"\/Date(1773070511000)\/","ResponsibleDepartment":4,"ResponsibleDepartmentName":"D\u00e9partement de l'int\u00e9rieur","ResponsibleDepartmentAbbreviation":"DFI","IsLeadingDepartment":true,"Tags":"15|1221|2841","Category":null,"Modified":"\/Date(1773070586530)\/","SubmissionDate":"\/Date(1772409600000)\/","SubmissionCouncil":1,"SubmissionCouncilName":"Conseil national","SubmissionCouncilAbbreviation":"CN","SubmissionSession":5212,"SubmissionLegislativePeriod":52,"FirstCouncil1":1,"FirstCouncil1Name":"Conseil national","FirstCouncil1Abbreviation":"CN","FirstCouncil2":null,"FirstCouncil2Name":null,"FirstCouncil2Abbreviation":null,"TagNames":"\u00c9conomie|Justice|Sant\u00e9"}}